newsfilter
← Latest News
GlobeNewswire·

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

  • Evaxion A/S will report first quarter 2026 financial results & provide a business update on Thursday May 7, 2026, before the Nasdaq CM opens.
  • Executive Management will host a conference call & webcast at 14:30 CET (08:30 EST) to present results & answer questions.
  • Participants must register via a provided link to receive dial-in numbers & a unique PIN code for the conference call.
  • The webcast can be accessed via a specific link, with a recording available on the company website shortly after the event.
  • Mads Kronborg serves as Vice President of Investor Relations & Communication & is the designated contact for media & investor inquiries.
  • Evaxion utilizes its proprietary AI-Immunology™ platform to accelerate target discovery, drug design, & development for cancer & infectious disease vaccines.
  • The company maintains a clinical pipeline of personalized & off-the-shelf cancer vaccine candidates, plus prophylactic candidates for infectious diseases.
  • The announcement includes forward-looking statements subject to risks such as financial needs, trial success, regulatory hurdles, & market acceptance.